Your browser doesn't support javascript.
loading
Rare Functional Variant in TM2D3 is Associated with Late-Onset Alzheimer's Disease.
Jakobsdottir, Johanna; van der Lee, Sven J; Bis, Joshua C; Chouraki, Vincent; Li-Kroeger, David; Yamamoto, Shinya; Grove, Megan L; Naj, Adam; Vronskaya, Maria; Salazar, Jose L; DeStefano, Anita L; Brody, Jennifer A; Smith, Albert V; Amin, Najaf; Sims, Rebecca; Ibrahim-Verbaas, Carla A; Choi, Seung-Hoan; Satizabal, Claudia L; Lopez, Oscar L; Beiser, Alexa; Ikram, M Arfan; Garcia, Melissa E; Hayward, Caroline; Varga, Tibor V; Ripatti, Samuli; Franks, Paul W; Hallmans, Göran; Rolandsson, Olov; Jansson, Jan-Håkon; Porteous, David J; Salomaa, Veikko; Eiriksdottir, Gudny; Rice, Kenneth M; Bellen, Hugo J; Levy, Daniel; Uitterlinden, Andre G; Emilsson, Valur; Rotter, Jerome I; Aspelund, Thor; O'Donnell, Christopher J; Fitzpatrick, Annette L; Launer, Lenore J; Hofman, Albert; Wang, Li-San; Williams, Julie; Schellenberg, Gerard D; Boerwinkle, Eric; Psaty, Bruce M; Seshadri, Sudha; Shulman, Joshua M.
Afiliación
  • Jakobsdottir J; Icelandic Heart Association, Kopavogur, Iceland.
  • van der Lee SJ; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Bis JC; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Chouraki V; Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Li-Kroeger D; Framingham Heart Study, Framingham, Massachusetts, United States of America.
  • Yamamoto S; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Grove ML; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital Houston, Texas, United States of America.
  • Naj A; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Vronskaya M; Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital Houston, Texas, United States of America.
  • Salazar JL; Program in Developmental Biology, Baylor College of Medicine, Houston, Texas, United States of America.
  • DeStefano AL; School of Public Health, Human Genetics Center, The University of Texas Health Science Center at Houston, Houston, Texas, United States of America.
  • Brody JA; Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America.
  • Smith AV; Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
  • Amin N; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
  • Sims R; Framingham Heart Study, Framingham, Massachusetts, United States of America.
  • Ibrahim-Verbaas CA; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
  • Choi SH; Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, United States of America.
  • Satizabal CL; Icelandic Heart Association, Kopavogur, Iceland.
  • Lopez OL; Faculty of Medicine, University of Iceland, Reykjavik, Iceland, United States of America.
  • Beiser A; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Ikram MA; Institute of Psychological Medicine and Clinical Neurosciences, Medical Research Council (MRC) Centre for Neuropsychiatric Genetics & Genomics, Cardiff University, Cardiff, United Kingdom.
  • Garcia ME; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Hayward C; Department of Neurology, Erasmus University Medical Center, CA Rotterdam, The Netherlands.
  • Varga TV; Framingham Heart Study, Framingham, Massachusetts, United States of America.
  • Ripatti S; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
  • Franks PW; Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Hallmans G; Framingham Heart Study, Framingham, Massachusetts, United States of America.
  • Rolandsson O; Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, United States of America.
  • Jansson JH; Boston University School of Medicine, Boston, Massachusetts, United States of America.
  • Porteous DJ; Framingham Heart Study, Framingham, Massachusetts, United States of America.
  • Salomaa V; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts, United States of America.
  • Eiriksdottir G; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Rice KM; Department of Neurology, Erasmus University Medical Center, CA Rotterdam, The Netherlands.
  • Bellen HJ; Departments of Radiology, Erasmus University Medical Center, CA Rotterdam, The Netherlands.
  • Levy D; Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Bethesda, Maryland, United States of America.
  • Uitterlinden AG; MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Emilsson V; Generation Scotland, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Rotter JI; Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmö, Sweden.
  • Aspelund T; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • O'Donnell CJ; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America.
  • Fitzpatrick AL; Department of Biobank Research, Umeå University, Umeå, Sweden.
  • Launer LJ; Department of Public Health & Clinical Medicine, Section for Family Medicine, Umeå University, Umeå, Sweden.
  • Hofman A; Department of Public Health & Clinical Medicine, Umeå University Hospital, Umeå, Sweden.
  • Wang LS; Research Unit, Skellefteå Hospital, Skellefteå, Sweden.
  • Williams J; Generation Scotland, Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Schellenberg GD; Centre for Genomic and Experimental Medicine, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
  • Boerwinkle E; National Institute for Health and Welfare, Helsinki, Finland.
  • Psaty BM; Icelandic Heart Association, Kopavogur, Iceland.
  • Seshadri S; Department of Biostatistics, University of Washington, Seattle, Washington, United States of America.
  • Shulman JM; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.
PLoS Genet ; 12(10): e1006327, 2016 Oct.
Article en En | MEDLINE | ID: mdl-27764101
ABSTRACT
We performed an exome-wide association analysis in 1393 late-onset Alzheimer's disease (LOAD) cases and 8141 controls from the CHARGE consortium. We found that a rare variant (P155L) in TM2D3 was enriched in Icelanders (~0.5% versus <0.05% in other European populations). In 433 LOAD cases and 3903 controls from the Icelandic AGES sub-study, P155L was associated with increased risk and earlier onset of LOAD [odds ratio (95% CI) = 7.5 (3.5-15.9), p = 6.6x10-9]. Mutation in the Drosophila TM2D3 homolog, almondex, causes a phenotype similar to loss of Notch/Presenilin signaling. Human TM2D3 is capable of rescuing these phenotypes, but this activity is abolished by P155L, establishing it as a functionally damaging allele. Our results establish a rare TM2D3 variant in association with LOAD susceptibility, and together with prior work suggests possible links to the ß-amyloid cascade.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tropomiosina / Proteínas de Drosophila / Receptores Notch / Enfermedad de Alzheimer / Proteínas de la Membrana Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: PLoS Genet Asunto de la revista: GENETICA Año: 2016 Tipo del documento: Article País de afiliación: Islandia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Tropomiosina / Proteínas de Drosophila / Receptores Notch / Enfermedad de Alzheimer / Proteínas de la Membrana Tipo de estudio: Risk_factors_studies Límite: Aged / Animals / Female / Humans / Male País/Región como asunto: Europa Idioma: En Revista: PLoS Genet Asunto de la revista: GENETICA Año: 2016 Tipo del documento: Article País de afiliación: Islandia